Turley Tamiel N, Theis Jeanne L, Evans Jared M, Fogarty Zachary C, Gulati Rajiv, Hayes Sharonne N, Tweet Marysia S, Olson Timothy M
Molecular Pharmacology and Experimental Therapeutics Track, Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN 55905, USA.
Cardiovascular Genetics Research Laboratory, Mayo Clinic, Rochester, MN 55905, USA.
J Cardiovasc Dev Dis. 2023 Sep 12;10(9):393. doi: 10.3390/jcdd10090393.
Rare familial spontaneous coronary artery dissection (SCAD) kindreds implicate genetic disease predisposition and provide a unique opportunity for candidate gene discovery. Whole-genome sequencing was performed in fifteen probands with non-syndromic SCAD who had a relative with SCAD, eight of whom had a second relative with extra-coronary arteriopathy. Co-segregating variants and associated genes were prioritized by quantitative variant, gene, and disease-level metrics. Curated public databases were queried for functional relationships among encoded proteins. Fifty-four heterozygous coding variants in thirteen families co-segregated with disease and fulfilled primary filters of rarity, gene variation constraint, and predicted-deleterious protein effect. Secondary filters yielded 11 prioritized candidate genes in 12 families, with high arterial tissue expression ( = 7), high-confidence protein-level interactions with genes associated with SCAD previously ( = 10), and/or previous associations with connective tissue disorders and aortopathies ( = 3) or other vascular phenotypes in mice or humans ( = 11). High-confidence associations were identified among 10 familial SCAD candidate-gene-encoded proteins. A collagen-encoding gene was identified in five families, two with distinct variants in COL4A2. Familial SCAD is genetically heterogeneous, yet perturbations of extracellular matrix, cytoskeletal, and cell-cell adhesion proteins implicate common disease-susceptibility pathways. Incomplete penetrance and variable expression suggest genetic or environmental modifiers.
罕见的家族性自发性冠状动脉夹层(SCAD)家系提示存在遗传疾病易感性,并为候选基因的发现提供了独特的机会。对15名非综合征性SCAD先证者进行了全基因组测序,这些先证者有一名亲属患有SCAD,其中8人有第二名患有冠状动脉外动脉病变的亲属。通过定量变异、基因和疾病水平指标对共分离变异和相关基因进行优先级排序。查询经过整理的公共数据库以了解编码蛋白之间的功能关系。13个家族中的54个杂合编码变异与疾病共分离,并满足罕见性、基因变异限制和预测有害蛋白效应的主要筛选标准。二级筛选在12个家族中产生了11个优先候选基因,这些基因在动脉组织中高表达(=7),与先前与SCAD相关的基因有高可信度的蛋白水平相互作用(=10),和/或先前与结缔组织疾病和主动脉病变(=3)或小鼠或人类的其他血管表型(=11)有关联。在10个家族性SCAD候选基因编码蛋白之间鉴定出高可信度的关联。在5个家族中鉴定出一个胶原蛋白编码基因,其中2个家族在COL4A2中有不同的变异。家族性SCAD在遗传上是异质性的,但细胞外基质、细胞骨架和细胞间粘附蛋白的扰动暗示了常见的疾病易感性途径。不完全外显率和可变表达提示存在遗传或环境修饰因子。